The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.
October 25th 2024
The theme of our recent Nashville Institute for Value-Based Medicine® event was ”Bringing the Future to the Present in Cancer Care.”
Gain expert insights to the phase 3 NADINA trial and learn more about unmet needs in melanoma management with this Post Conference Perspectives.
IO-TKI Combinations Have Potential as Preferred First-line mRCC Therapy
Murine Study Suggests Novel I-O Combo May Be Effective in CRC